PENTOXIFYLLINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pentoxifylline, and when can generic versions of Pentoxifylline launch?
Pentoxifylline is a drug marketed by Ani Pharms, Apotex, Heritage Pharms, Impax Labs, Pliva, Rising, and Valeant Pharms. and is included in nine NDAs.
The generic ingredient in PENTOXIFYLLINE is pentoxifylline. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pentoxifylline
A generic version of PENTOXIFYLLINE was approved as pentoxifylline by ANI PHARMS on July 9th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PENTOXIFYLLINE?
- What are the global sales for PENTOXIFYLLINE?
- What is Average Wholesale Price for PENTOXIFYLLINE?
Summary for PENTOXIFYLLINE
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 9 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 102 |
Clinical Trials: | 157 |
Patent Applications: | 4,114 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PENTOXIFYLLINE |
DailyMed Link: | PENTOXIFYLLINE at DailyMed |
![PENTOXIFYLLINE drug patent expirations Drug patent expirations by year for PENTOXIFYLLINE](/p/graph/s/t/PENTOXIFYLLINE-patent-expirations.png)
![Drug Prices for PENTOXIFYLLINE](/p/graph/drug-price/PENTOXIFYLLINE.png)
Recent Clinical Trials for PENTOXIFYLLINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sunnybrook Health Sciences Centre | Phase 3 |
Bhabha Atomic Research Centre (BARC) | Phase 2 |
Tata Memorial Centre | Phase 2 |
Pharmacology for PENTOXIFYLLINE
Drug Class | Blood Viscosity Reducer |
Physiological Effect | Hematologic Activity Alteration |
Medical Subject Heading (MeSH) Categories for PENTOXIFYLLINE
Anatomical Therapeutic Chemical (ATC) Classes for PENTOXIFYLLINE
US Patents and Regulatory Information for PENTOXIFYLLINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ani Pharms | PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 074878-001 | Jul 9, 1997 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Pliva | PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 074874-001 | May 25, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Apotex | PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 075191-001 | Jun 9, 1999 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Rising | PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 074425-001 | Jul 8, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ani Pharms | PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 075107-001 | Sep 4, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ani Pharms | PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 075199-001 | Sep 3, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |